Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma

In conclusion, sPD-L2 and sLAG-3 expression may serve as a potential biomarker for predicting IO combination therapy efficacy.PMID:38668032 | PMC:PMC11049572 | DOI:10.3390/curroncol31040129

Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Kosuke Ueda Keiichiro Uemura Naoki Ito Yuya Sakai Satoshi Ohnishi Hiroki Suekane Hirofumi Kurose Tasuku Hiroshige Katsuaki Chikui Kiyoaki Nishihara Makoto Nakiri Shigetaka Suekane Sachiko Ogasawara Hirohisa Yano Tsukasa Igawa Source Type: research